113 related articles for article (PubMed ID: 1801628)
1. Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia.
Mallolas J; Gatell JM; Miró JM; Marco F; Bisbe J; Jiménez de Anta MT; Soriano E
Antibiot Chemother (1971); 1991; 44():106-14. PubMed ID: 1801628
[No Abstract] [Full Text] [Related]
2. Clinical significance of polymicrobial versus monomicrobial bacteremia involving Pseudomonas aeruginosa.
Aliaga L; Mediavilla JD; Llosá J; Miranda C; Rosa-Fraile M
Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):871-4. PubMed ID: 11152313
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas endocarditis in the Detroit Medical Center. 1969-1972.
Reyes MP; Palutke WA; Wylin RF
Medicine (Baltimore); 1973 May; 52(3):173-94. PubMed ID: 20407410
[No Abstract] [Full Text] [Related]
4. [Bacteremia caused by Pseudomonas aeruginosa in patients with AIDS].
Bouza Santiago E; Blázquez Garrido R; Rodríguez-Creixems M; Moreno Guillén S; Miralles Martín P; Alonso Fernández R
Rev Clin Esp; 1996 Oct; 196(10):698-702. PubMed ID: 9005473
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors.
Grisaru-Soen G; Lerner-Geva L; Keller N; Berger H; Passwell JH; Barzilai A
Pediatr Infect Dis J; 2000 Oct; 19(10):959-63. PubMed ID: 11055596
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.
Vidal F; Mensa J; Martínez JA; Almela M; Marco F; Gatell JM; Richart C; Soriano E; Jiménez de Anta MT
Eur J Clin Microbiol Infect Dis; 1999 Jul; 18(7):473-7. PubMed ID: 10482023
[TBL] [Abstract][Full Text] [Related]
8. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia due to Pseudomonas aeruginosa in children with AIDS.
Flores G; Stavola JJ; Noel GJ
Clin Infect Dis; 1993 May; 16(5):706-8. PubMed ID: 8507763
[TBL] [Abstract][Full Text] [Related]
10. A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime.
Ratliff AR; Gentry CA; Williams RJ
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):376-381. PubMed ID: 28087171
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
Hernández-Tejedor A; Merino-Vega CD; Martín-Vivas A; Ruiz de Luna-González R; Delgado-Iribarren A; Gabán-Díez Á; Temprano-Gómez I; de la Calle-Pedrosa N; González-Jiménez AI; Algora-Weber A
Infection; 2017 Feb; 45(1):115-117. PubMed ID: 27670678
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
[TBL] [Abstract][Full Text] [Related]
13. Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia.
Tang PC; Lee CC; Li CW; Li MC; Ko WC; Lee NY
J Microbiol Immunol Infect; 2017 Aug; 50(4):486-493. PubMed ID: 26455486
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity.
Mennink-Kersten MA; Ruegebrink D; Verweij PE
Clin Infect Dis; 2008 Jun; 46(12):1930-1. PubMed ID: 18540808
[No Abstract] [Full Text] [Related]
15. Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
Marra AR; Bearman GM; Wenzel RP; Edmond MB
BMC Infect Dis; 2006 Aug; 6():132. PubMed ID: 16916466
[TBL] [Abstract][Full Text] [Related]
16. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes.
Chatzinikolaou I; Abi-Said D; Bodey GP; Rolston KV; Tarrand JJ; Samonis G
Arch Intern Med; 2000 Feb; 160(4):501-9. PubMed ID: 10695690
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint.
Tam VH; Gamez EA; Weston JS; Gerard LN; Larocco MT; Caeiro JP; Gentry LO; Garey KW
Clin Infect Dis; 2008 Mar; 46(6):862-7. PubMed ID: 18279040
[TBL] [Abstract][Full Text] [Related]
18. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
19. A model to predict mortality following Pseudomonas aeruginosa bacteremia.
Hirsch EB; Cottreau JM; Chang KT; Caeiro JP; Johnson ML; Tam VH
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):97-102. PubMed ID: 22056006
[TBL] [Abstract][Full Text] [Related]
20. Tree-structured survival analysis of patients with Pseudomonas aeruginosa bacteremia: A multicenter observational cohort study.
Yoon YK; Kim HA; Ryu SY; Lee EJ; Lee MS; Kim J; Park SY; Yang KS; Kim SW;
Diagn Microbiol Infect Dis; 2017 Feb; 87(2):180-187. PubMed ID: 27863948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
